Vimarsana
Biggest News Aggregation in the World

Page 10 - Adenosine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adenosine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adenosine Today - Breaking & Trending Today

Researchers identify inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase - Vimarsana News

Researchers identify inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase

A recent study identified inhibitors for SARS-CoV-2 non-structural protein 14 (Nsp14).

Can diets reverse or delay aging? - Vimarsana News

Can diets reverse or delay aging?

A new study published in the journal Science aimed to summarize the commonly studied anti-aging dietary interventions and their impact on human health and longevity.

Review shows metformin usage to be associated with better COVID-19 outcomes - Vimarsana News

Review shows metformin usage to be associated with better COVID-19 outcomes

Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.

iTeos Provides Business Updates and Clinical Development Plans for 2023 - Vimarsana News

iTeos Provides Business Updates and Clinical Development Plans for 2023

- 2023 will produce significant advances for both anti-TIGIT monoclonal antibody EOS-448/GSK4428859A and adenosine A2A receptor antagonist inupadenant - Eleven clinical trials planned or ongoing... | January 9, 2023

Innate Pharma SA: Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022 - Vimarsana News

Innate Pharma SA: Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022

Phase 1 data for IPH5201, a CD39-blocking monoclonal antibody, as monotherapy or in combination with durvalumab, in advanced solid tumors to be presented by partner AstraZeneca Preclinical